CAS ID: | 107724-20-9 |
Molecular Formula: | C24H30O6 |
Molecular Weight: | 414.5 g/mol |
Monoisotopic Mass: | 414.2042 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | SC-6611O | INSPRA | SC-66110 | EPLERENONE |
Analysis: | Drug repositioning mechanism analysis |
InChI: | InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1 | See All |
InChI Key: | JUKPWJGBANNWMW-VWBFHTRKSA-N | |
Smiles: | COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14 | See All |
Molfile: | Download |
Target ID | Name | Interaction |
---|---|---|
T0536 | Mineralocorticoid receptor | antagonist |
Reference Record 1
Reference Record 2
Reference Record 3
PubMed ID | 29216985 | Target ID | |
Uniprot ID | Name | ||
Model | sheep | Fibrosis Disease | Cardiac fibrosis |
Process I | |||
Process II | myofibroblasts proliferation | ||
Process III | prevenet collagen deposition | ||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT00401856 | Disease | Cardiac fibrosis |
Phase | Phase 4 | Status | Unknown |
First Received | November 22, 2006 | Last Verified | December 11, 2008 |
Sponsor | Royal Brompton & Harefield NHS Foundation Trust |
Trial Record 2
ClinicalTrial ID | NCT01971593 | Disease | Cardiac fibrosis |
Phase | Phase 4 | Status | Terminated |
First Received | October 29, 2013 | Last Verified | May 4, 2018 |
Sponsor | Washington University School of Medicine |
Trial Record 3
ClinicalTrial ID | NCT01801228 | Disease | Liver fibrosis |
Phase | Phase 2 | Status | Withdrawn |
First Received | February 28, 2013 | Last Verified | January 15, 2016 |
Sponsor | Emma Nilsson |
Trial Record 4
ClinicalTrial ID | NCT02740179 | Disease | Cardiac fibrosis |
Phase | Not Applicable | Status | Recruiting |
First Received | April 15, 2016 | Last Verified | March 13, 2019 |
Sponsor | Massachusetts General Hospital |
PubChem: | 443872 |
ChEMBL: | CHEMBL1095097 |